Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05743699 · ClinicalTrials.gov registry record · NA
Adaptation and Evaluation of Bright Horizons
A NA study of Substance Use and Alcohol Abuse, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05743699: Recruiting NA study of Substance Use and Alcohol Abuse, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT05743699 is a NA study of Substance Use and Alcohol Abuse that is actively recruiting participants, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 100 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05743699, a NA study of Substance Use and Alcohol Abuse, is actively recruiting participants, sponsored by Johns Hopkins Bloomberg School of Public Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test if a program called 'Bright Horizons' is effective at reducing binge substance use among adolescents. Bright Horizons is a culturally adapted intervention developed and tested through a partnership between The White Mountain Apache Tribe and Johns Hopkins University. Bright Horizons is a brief intervention that teaches emotion regulation, coping skills, and problem solving. The intervention also uses goal setting to reduce alcohol and other substance use and to connect to individuals with treatment.
Primary Outcome
Alcohol use over the past 30 days (Timeline Followback to assess number of drinking days and number of drinks per day)
Conditions Studied
Interventions
- BEHAVIORAL Bright Horizons
- BEHAVIORAL Case Management
Study Locations (1)
Arizona
- Johns Hopkins Center for Indigenous Health - Whiteriver Site - Whiteriver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-07-17 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What NCT05743699 shows while recruiting
NCT05743699 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Bright Horizons is the first listed.
NCT05743699 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05743699 about?
NCT05743699 is a clinical study titled "Adaptation and Evaluation of Bright Horizons". This study will test if a program called 'Bright Horizons' is effective at reducing binge substance use among adolescents. Bright Horizons is a culturally adapted intervention developed and tested through a partnership between The White Mountain Apache Tribe and Johns Hopkins University. Bright Hor...
What is the current status of trial NCT05743699?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-07-17. Estimated completion is 2027-01-31.
What conditions does trial NCT05743699 study?
This clinical trial studies the following conditions: Substance Use, Alcohol Abuse.
What interventions are being tested in trial NCT05743699?
The interventions under investigation include: Bright Horizons (BEHAVIORAL), Case Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT05743699?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05743699 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05743699's enrollment target sits among peer trials
100 63rd of 88 higher than 26 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
-
Primary Connections for Youth and Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI